Anti-IgE
Use
This ELISA measures IgG antibodies specific for IgE. A result of normal indicates that the level of IgG anti-IgE antibodies is similar to that seen in a population of healthy individuals. A result of elevated indicates an increased level of IgG anti-IgE antibodies compared to healthy individuals. These autoantibodies have been implicated as a causative agent in autoimmune chronic urticaria and atopic dermatitis.
Special Instructions
The test is performed at the Eurofins Viracor laboratory and is available for ordering by New York State clients.
Limitations
This test has not been cleared or approved by the U.S. Food and Drug Administration. The performance characteristics were determined by Eurofins Viracor.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
Result Turnaround Time
7-11 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.0 mL
Minimum Volume
0.5 mL
Container
Red Top
Collection Instructions
Draw blood in a plain red-top tube(s), serum gel tube(s) is acceptable. Spin down and send 1.0 mL of serum ambient in a plastic vial.
Causes for Rejection
Gross hemolysis, Gross lipemia, Gross icterus
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 7 days |
| Refrigerated | 7 days |
| Frozen | 28 days |